scout
Opinion|Videos|December 21, 2024

SEQUOIA Trial: Updates from ASH 2024

Experts review the 5-year results of the phase 3 SEQUOIA trial evaluating treatment options for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma at the 66th American Society of Hematology Annual Meeting and Exposition 2024.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME